Lani R. Wegrzyn

No ORCID on file · 5 papers in corpus · active 2019-2021

Study types

  • article 4
  • peer-review 1

Condition tags

  • endometriosis 5
  • mesh:D004715 1
article 2021
Chronic opioid use and complication risks in women with endometriosis: A cohort study in US administrative claims
Pharmacoepidemiology and drug safety ·doi:10.1002/pds.5209

BACKGROUND: Women with endometriosis are prescribed opioids for pain relief but may be vulnerable to chronic opioid use given their comorbidity profile. METHODS: A cohort study was conducted in the Clinformatics™ DataMart database between 2…

peer-review 2020
Author response for "Estimating the effect of elagolix treatment for endometriosis on post‐menopausal bone outcomes: a model bridging registrational phase III trials to an older real‐world population"
·doi:10.1002/jbm4.10401/v2/response1
article 2020
Estimating the Effect of Elagolix Treatment for Endometriosis on Postmenopausal Bone Outcomes: A Model Bridging Phase III Trials to an Older Real‐World Population
JBMR plus ·doi:10.1002/jbm4.10401

ABSTRACT Elagolix, a gonadotrophin‐releasing hormone antagonist, is used in premenopausal women with endometriosis. There is a risk of bone loss with elagolix, but the long‐term effects of BMD loss later in life cannot be directly assessed …

article 2019
Predictors of Chronic Opioid Use Among Women With Endometriosis [18J]
·doi:10.1097/01.aog.0000558834.25763.06

INTRODUCTION: Women with endometriosis are prescribed opioids for pain relief but may have other risk factors for chronic opioid use. The identification of predictors of chronic use in this population may provide clinical guidance for treat…

article 2019
Risk of Chronic Opioid Use Among Women With Endometriosis [16M]
·doi:10.1097/01.aog.0000559289.36694.14

INTRODUCTION: Women with endometriosis may be prescribed opioids for management of endometriosis-related pain symptoms or in the context of surgical procedures. Once exposed, these women may be vulnerable to chronic opioid use given their c…